Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daylight PDT for Actinic Keratosis
NCT03013647Unknown
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Sep 2016
- Primary completion
- Apr 2017
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
Open-label, single-arm trial of methyl aminolevulinate in actinic keratosis (AK), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Primary endpoint: Clinical improvement at 3 months. Status: unknown.
02
Drugs
methyl aminolevulinate
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT03013647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03013647.